Avadel Pharmaceuticals’ $2.1B acquisition by Alkermes underscores Lumryz’s strong growth and profitability, with added upside tied to FDA approval for...
Read moreDetailsNvidia (NVDA) has just become the first company in history to cross the $5 trillion market capitalization mark, a feat...
Read moreDetailsAvanos Medical’s sale of its Game Ready unit to WRS Group sharpens focus on core pain and nutrition lines, streamlining...
Read moreDetailsDatavault AI’s expansion with new hubs in Philadelphia, Georgia, and London signals bold growth as it scales data monetization tech...
Read moreDetailsGigacloud Technology’s acquisition of New Classic Home Furnishing boosts its sourcing network and U.S. reach, signaling strategic growth and supply-chain...
Read moreDetailsViomi Technology’s $20M share buyback through 2027 signals confidence post major restructuring and renewed focus on home water systems, sparking...
Read moreDetailsQualcomm (QCOM) soared over than 20% on Monday after the chipmaker announced a bold new plan to enter the data...
Read moreDetailsClear Channel Outdoor soars 27% after reports that Abu Dhabi’s Mubadala Capital may pursue a takeover. Despite heavy debt, the...
Read moreDetailsBeyond Meat crashes below $1 for the first time, marking a 99% drop from its peak. A massive debt swap,...
Read moreDetailsNeogen Corporation shares jumped 23% after solid Q1 results and a new cost-cutting plan that trims 10% of its workforce,...
Read moreDetailsThese Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.
CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE
To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.
If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.